Amlodipine Market Revenue was valued at USD 1.8 Billion in 2024 and is estimated to reach USD 2.5 Billion by 2033, growing at a CAGR of 4.2% from 2026 to 2033.
South Korea's Amlodipine Market: Navigating Industry Demands Amidst Rising Hypertension
The Amlodipine Market in South Korea is experiencing notable growth, driven by an aging population and increasing prevalence of hypertension. In 2019, amlodipine consumption reached 32.6 DIDs, generating approximately $190 million in revenue. Fixed-dose combinations, such as telmisartan+amlodipine and valsartan+amlodipine, also saw significant consumption, with 34.4 and 34.2 DIDs respectively, each contributing around $180–190 million in sales.
Key factors influencing this market include:
Demographic Shifts: An aging population contributes to higher hypertension rates, increasing demand for antihypertensive medications.
Healthcare Policies: Government initiatives aim to improve access to healthcare, further driving the demand for effective treatments like amlodipine.
Market Dynamics: The pharmaceutical market in South Korea reached approximately 31.7 trillion won in 2023, with prescription drugs, including antihypertensives, constituting a significant portion.
Despite the presence of generic versions, the market share for generics in antihyperlipidemic agents remains low, indicating potential for growth in the generic segment of the amlodipine market. The South Korean government's efforts to promote the use of generic medicines could influence this trend, potentially leading to increased competition and accessibility.
In the context of industry requirements, pharmaceutical companies are focusing on:
Research and Development: Investing in innovative drug formulations and delivery methods to enhance treatment efficacy and patient compliance.
Strategic Partnerships: Collaborating with local and international firms to expand market reach and share technological advancements.
Regulatory Compliance: Navigating the complex regulatory landscape to ensure timely approval and market entry of new products.
Overall, the amlodipine market in South Korea presents opportunities for growth, driven by demographic trends and healthcare initiatives. Companies that adapt to these dynamics and align with industry requirements are well-positioned to succeed in this evolving landscape.
Get an In-Depth Research Analysis of the South Korea Amlodipine Market Size And Forecast [2025-2032]
Â
Novartis
Pfizer
Lek
TEVA
Macleods Pharmaceuticals
Caraco Pharmaceutical
Sanis Health
Jamp Pharma
Accel Pharma
Jubilant Generics
Novartis
Florida DOH Central Pharmacy
Shanghai Disainuo Biopharmaceutical
Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical
Beijing Wansheng Pharmaceutical
Beijing Honglin Pharmaceutical
Beijing Maidihai Pharmaceutical
China Resources Saike Pharmaceutical
Beijing Jiulong Pharmaceutical
Tiannian Pharmaceutical
Chengdu Diao Pharmaceutical Group
Yangtze Pharmaceutical
Kunming Sino Pharmaceutical
Wuhan Dongxin Pharmaceutical Technology
Jiangsu Wangao Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Jiangsu Huanghe Pharmaceutical
Zhejiang Jingxin Pharmaceutical
Zhejiang Jianfeng Pharmaceutical
Hunan Qianjinxieli Pharmaceutical
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Amlodipine Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Amlodipine Market
Tablet
Oral Suspension
Coated Tablet
Extended-Release Formulation
Hypertension (High Blood Pressure)
Angina (Chest Pain)
Heart Failure
Other Cardiovascular Disorders
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Clinic Pharmacy
Hospitals
Homecare Settings
Long-term Care Facilities
Outpatient Clinics
Adults (Age 18-64)
Seniors (Age 65 and above)
Pediatric (Children and Adolescents)
Special Population (Pregnant Women, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Amlodipine Market Research Analysis
1. Introduction of the South Korea Amlodipine Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Amlodipine Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Amlodipine Market, By Type
6. South Korea Amlodipine Market, By Application
7. South Korea Amlodipine Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Amlodipine Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/